Cargando…
Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas
BACKGROUND: The transcription factor forkhead box D3 (FOXD3) plays important roles in the development of neural crest and has been shown to suppress the development of various cancers. However, the expression and its potential biological roles of FOXD3 in high-grade gliomas (HGGs) remain unknown. ME...
Autores principales: | Du, Wei, Pang, Changhe, Wang, Dongliang, Zhang, Qingjun, Xue, Yake, Jiao, Hongliang, Zhan, Lei, Ma, Qian, Wei, Xinting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444112/ https://www.ncbi.nlm.nih.gov/pubmed/26011451 http://dx.doi.org/10.1371/journal.pone.0127976 |
Ejemplares similares
-
Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells
por: Du, Wei, et al.
Publicado: (2021) -
Online calculator to predict early mortality in patient with surgically treated recurrent lower-grade glioma
por: Wei, Ruolun, et al.
Publicado: (2022) -
High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022) -
Prognostic value and immune-infiltration pattern of FOXD3-AS1 in patients with glioma
por: Chen, Zhenhua, et al.
Publicado: (2023) -
LncRNA FOXD1‐AS1 acts as a potential oncogenic biomarker in glioma
por: Gao, Yuan‐Feng, et al.
Publicado: (2019)